
Keywords: AGE; advanced glycation end-product; GSH; reduced glutathione; MGO; methylglyoxal; 3-DG; 3-deoxyglucosone; CML; Nε-(carboxymethyl)-lysine; CEL; Nε-(carboxyethyl)-lysine; ROS; reactive oxygen species; AMD; age-related macular degeneration; RPE; retinal p